37 | Somatostatin Receptors (Somatostatin Receptor)IBA
12/2021
-
04/2002 |
35 | Radioisotopes (Radionuclides)IBA
11/2020
-
04/2002 |
35 | Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
05/2016
-
04/2002 |
26 | Peptide Receptors (Peptide Receptor)IBA
01/2020
-
12/2002 |
23 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
03/2022
-
04/2002 |
21 | Peptides (Polypeptides)IBA
11/2020
-
12/2002 |
20 | Octreotide (Sandostatin)FDA LinkGeneric
12/2021
-
04/2002 |
18 | Pentetic Acid (DTPA)FDA LinkGeneric
05/2014
-
04/2002 |
14 | Tyr(3)- octreotateIBA
11/2015
-
04/2002 |
12 | Bombesin Receptors (Bombesin Receptor)IBA
11/2020
-
01/2007 |
11 | BombesinIBA
03/2019
-
12/2002 |
10 | Neprilysin (Neutral Endopeptidase)IBA
11/2020
-
01/2014 |
8 | AcidsIBA
04/2008
-
12/2002 |
7 | phosphoramidonIBA
11/2020
-
01/2014 |
7 | 3-Tyr-octreotideIBA
03/2010
-
04/2002 |
6 | Cholecystokinin (Pancreozymin)IBA
03/2022
-
07/2009 |
6 | GastrinsIBA
03/2022
-
07/2009 |
5 | Lysine (L-Lysine)FDA Link
11/2014
-
12/2005 |
5 | yttrium(III)- 1,4,7,10- tetraazacyclotetradecane- N,N',N'',N'''- tetraacetic acidIBA
03/2010
-
01/2005 |
5 | RadiopharmaceuticalsIBA
07/2009
-
04/2002 |
4 | lutetium Lu 177 dotatateIBA
12/2021
-
05/2014 |
4 | NeurotensinIBA
10/2020
-
01/2005 |
4 | Biological ProductsIBA
03/2019
-
09/2010 |
4 | Gastrin-Releasing PeptideIBA
11/2013
-
12/2002 |
4 | Folic Acid (Vitamin M)FDA LinkGeneric
07/2011
-
08/2007 |
4 | pentetreotide (OctreoScan)FDA Link
05/2010
-
04/2003 |
4 | 177Lu-octreotateIBA
08/2007
-
10/2003 |
3 | minigastrinIBA
02/2016
-
03/2003 |
3 | Amifostine (Ethyol)FDA LinkGeneric
05/2012
-
01/2007 |
3 | Amino AcidsFDA Link
12/2010
-
04/2002 |
3 | CreatinineIBA
05/2007
-
04/2002 |
3 | Dopamine D2 Receptors (Dopamine D2 Receptor)IBA
04/2007
-
12/2003 |
3 | Therapeutic UsesIBA
07/2004
-
04/2002 |
2 | Chelating AgentsIBA
03/2022
-
10/2003 |
2 | sacubitril and valsartan sodium hydrate drug combinationIBA
11/2020
-
10/2020 |
2 | Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
10/2020
-
06/2020 |
2 | Lisinopril (Prinivil)FDA LinkGeneric
10/2020
-
06/2020 |
2 | Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
10/2020
-
06/2020 |
2 | Vasopeptidase InhibitorsIBA
10/2020
-
12/2016 |
2 | 68Ga-SB3IBA
03/2019
-
01/2017 |
2 | Chromogranin AIBA
01/2018
-
09/2011 |
2 | Arginine (L-Arginine)FDA Link
12/2010
-
12/2005 |
2 | Hormones (Hormone)IBA
09/2010
-
04/2008 |
2 | AndrogensIBA
06/2010
-
01/2007 |
2 | indium-111-octreotideIBA
07/2009
-
01/2005 |
2 | Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA
07/2009
-
04/2008 |
2 | Substance PIBA
07/2009
-
01/2005 |
2 | Pemetrexed (MTA)FDA Link
04/2008
-
08/2007 |
2 | Folic Acid AntagonistsIBA
04/2008
-
08/2007 |
2 | Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2006
-
06/2003 |
2 | DobutamineFDA LinkGeneric
01/2006
-
09/2002 |
2 | Dexamethasone (Maxidex)FDA LinkGeneric
01/2006
-
08/2002 |
2 | Cholecystokinin B ReceptorIBA
04/2004
-
03/2003 |
1 | 1- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA
03/2022 |
1 | Lidocaine (Xylocaine)FDA LinkGeneric
01/2022 |
1 | Adenosine Triphosphate (ATP)IBA
01/2022 |
1 | Purinergic Receptors (Receptors, Purine)IBA
01/2022 |
1 | LBQ657IBA
11/2020 |